-
Eco-environmental standardization work dynamics in May
Time of Update: 2023-02-19
In order to further promote the standardization construction of the ecological environment system in our province, the Provincial Ecological Environment Standardization Technical Committee, organized
-
Lijiang Market Supervision Bureau: "Six prominences" strengthen salt quality and safety supervision
Time of Update: 2022-12-29
Carry out key inspections on issues such as operators' sales of salt from other provinces that do not meet the province's iodization standards, the sale of bulk salt or large package salt, the general rules for the labeling of prepackaged foods with salt packaging labels, and the production and sale of salt that infringes the exclusive right to use a registered trademark.
-
The installation of the first batch of panels in the Dalian Hengli Ethylene Substation of Sijian Electric Instrument was well received
Time of Update: 2022-08-17
, Ltd. took the initiative to plan ahead according to the construction characteristics of the engineering process undertaken, and actively coordinated the operating conditions to ensure the steady progress of the construction In order to ensure the control node of this panel installation, the Dalian Hengli Project Department of Sijian Electric Instrument Co.
-
JAMA Oncol: Vistusertib in combination with anastrozole for hormone receptor-positive endometrial cancer
Time of Update: 2022-08-12
. In conclusion, the results of this study show that the addition of anastrozole to the mTOR inhibitor Vistusertib can improve the progression-free rate, remission rate, prolong progression-free survival , and reduce adverse reactions in patients with hormone receptor-positive recurrent/metastatic endometrial cancer.
-
The major hazard source enterprises of hazardous chemicals in Jiangsu Province ushered in the first safety inspection and supervision this year
Time of Update: 2022-08-10
The coverage rate, the online entry rate of hidden problems found by inspection and supervision, and the completion rate of rectification are "four 100%" This special inspection and supervision will comprehensively investigate and control the production and operation (with storage) enterprises of hazardous chemicals that constitute major hazards, and the chemical and pharmaceutical enterprises that use hazardous chemicals for production, to ensure the self-inspection rate of enterprises and the cross-inspection between cities.
-
Obri Asia-Pacific Republic notified the results of quality and safety sampling of baking and flour milling products in the first quarter of 2022
Time of Update: 2022-05-16
Food Partner Network News Flour Quality and Safety Sampling Inspection Sampling results showed that the physical and chemical indicators, pollutants, radioactive substances, and pesticide and veterinary drug residue limits of the tested samples all met the requirements of regulations and standards, but some samples were found to be unqualified for microbial indicators (2.
-
Inner Mongolia announced the first batch of chemical parks up to the standard
Time of Update: 2022-03-02
Second, the chemical industry park (chemical concentration area) strictly prohibits the industrial structure adjustment guidance catalogue elimination, hazardous chemical construction projects that do not meet the safety production standards and immature processes, labor-intensive non-chemical enterprises and light industrial projects such as the food industry from entering the park.
-
Arthritis Rheumatol: Risk factors for diastolic dysfunction in patients with systemic sclerosis and its impact on mortality
Time of Update: 2022-01-07
Recently, a research article was published in Arthritis & Rheumatology, an authoritative journal in the field of rheumatic immunology , which aims to identify independent risk factors for diastolic dysfunction (DD) in patients with systemic sclerosis (SSc), and to evaluate the effects of DD on the death of SSc patients The impact of the rate .
-
Research Progress of Glucose Sensitive Insulin Intelligent Drug Delivery System
Time of Update: 2021-12-08
The pH-triggered insulin release system utilizes the gluconic acid produced when GOx oxidizes glucose, causing local pH to decrease, which in turn triggers changes in the carrier structure (dissociation, swelling, or collapse), and ultimately leads to drug release .
-
Lancet Diabetes Endocrinol: Cardiovascular, Mortality, and Renal Outcomes in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists-A systematic review and meta-analysis of randomized
Time of Update: 2021-12-01
Two types of anti-glycemic drugs-GLP-1 receptor agonists and SGLT2 inhibitors can reduce the risk of high-risk patients with type 2 diabetesHeart vascular events . GLP-1 receptor agonists reduce gly
-
JGH: Risk analysis of adverse events in patients with aspirin-related ulcer bleeding using proton pump inhibitors combined with aspirin or clopidogrel
Time of Update: 2021-08-03
This study aimed to compare the effects of aspirin and clopidogrel on the risk of major adverse cardiovascular events (MACE), UGIB, and mortality in patients at risk of bleeding .
-
Remedial action has achieved obvious results, Hebei's chemical industry safety accidents have achieved "double down
Time of Update: 2021-07-02
Global Coatings Network News: The reporter learned from the Hebei Provincial Emergency Management Department that from January to September this year, the number of accidents and deaths in the province has both decreased year-on-year.
-
Ann Rheum Dis: Non-steroidal anti-inflammatory drugs and the risk of death from COVID-19
Time of Update: 2021-06-29
This study analyzed the correlation between non-steroidal anti-inflammatory drugs (NSAIDs) and death from COVID-19 .
In the multivariate adjustment model, it was observed that compared with not using NSAID, the current risk of COVID-19-related death with NSAID is lower (HR 0.
-
Express | To benefit more stroke patients, Bojian capsule gets a new generation of thrombolytic therapy
Time of Update: 2021-05-21
Alfred Sandrock, head of research and development of Bojian Company, said that in the past 25 years, no new thrombolytic drug has been approved for the treatment of acute ischemic stroke.
Reference: [1] Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data.
-
Huntington's disease drug research has lost ground
Time of Update: 2021-04-13
Swiss pharmaceutical company Roche (Roche) recently announced that it will stop dosing in a phase III clinical study that is evaluating the effectiveness and safety of its research candidate drug tominersen in the treatment of Huntington's disease.